罕见或不寻常的非发酵阴性细菌:治疗方法和抗生素治疗选择
Nicholas Geremia1,2, Andrea Marino3, Andrea De Vito4
1Unit of Infectious Diseases, Department of Clinical Medicine, Ospedale "dell'Angelo", 30174 Venice, Italy.
Antibiotics (Basel, Switzerland)
|March 28, 2025
概括
罕见的非发酵格拉姆阴性细菌 (NFGNB) 是导致医疗保健感染的新兴病原体. 由于耐药性,有针对性的治疗是必不可少的,强调抗菌药物管理,以获得更好的患者结果.
科学领域:
- 医学微生物学 医学微生物学
- 传染性疾病 传染性疾病
- 抗微生物耐药性 抗微生物耐药性
背景情况:
- 非发酵格拉姆阴性细菌 (NFGNB) 是机会性病原体,与医疗相关的感染有关.
- 虽然已知常见的NFGNB,但较罕见的物种由于耐药性而存在重大新兴治疗挑战.
研究的目的:
- 审查罕见和不寻常的NFGNB,它们的临床重要性,耐药性模式和基于证据的治疗策略.
- 强调对这些具有挑战性的病原体进行量身定制的治疗方法和抗菌药物管理的需要.
主要方法:
- 使用主要科学数据库 (PubMed,Scopus,Web of Science) 进行了全面的文献审查.
- 专注于流行病学,抗菌素耐药性和罕见NFGNB治疗的研究被确定并分析.
主要成果:
- 罕见的NFGNB具有多种抵抗机制,包括β-乳糖酶的产生,排泄和毛孔变化.
- 治疗以物种特异性敏感性为指导,用于针对多药耐药菌株的新药和正在研究的组合疗法.
- 目前对于许多罕见的NFGNB感染存在有限的临床数据.
结论:
- 罕见NFGNB的发病率不断上升,需要提高临床意识和个性化治疗计划.
- 由于缺乏具体的临床指导方针,抗微生物管理和受敏感性引导的治疗对于管理这些感染至关重要.
相关概念视频
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
Acute Pyelonephritis II: Diagnostic Studies and Management
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Development of Antibiotic Resistance
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Atypical Pneumonia
Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...


